Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 24 July 2006 |
| Author/s |
author: Pier Luigi Zinzani |
| Publication date | July 24, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |